1-8 of 8
G Catania
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

G. Pica, S. Vagge, G. Beltrami, S. Nati, G. Catania, R. Corvò, A. M. Carella, MD
Journal: Blood
Blood (2011) 118 (21): 4523.
https://doi.org/10.1182/blood.V118.21.4523.4523
Published: 2011
Journal Articles

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

G. Pica, G. Catania, F. Castelli, C Repetto, A. M. Carella, MD, M. Mussap
Journal: Blood
Blood (2011) 118 (21): 4416.
https://doi.org/10.1182/blood.V118.21.4416.4416
Published: 2011
Journal Articles

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

A. M. Carella, G. Catania, G. Pica and G. Beltrami
Journal: Blood
Blood (2010) 116 (21): 4486.
https://doi.org/10.1182/blood.V116.21.4486.4486
Published: 2010
Journal Articles

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

A. M. Carella, A. Garuti, G. Cirmena, G. Catania, G. Pica, G. Beltrami, F. Patrone
Journal: Blood
Blood (2010) 116 (21): 4458.
https://doi.org/10.1182/blood.V116.21.4458.4458
Published: 2010
Journal Articles

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

A. M. Carella, G. Catania, G. Pica, G. Beltrami, S. Nati, R. Vimercati, A. Congiu, E. Rossi, M. Spriano
Journal: Blood
Blood (2009) 114 (22): 4109.
https://doi.org/10.1182/blood.V114.22.4109.4109
Published: 2009
Journal Articles

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

A. M. Carella, E. Todisco, L. Castagna, A. Santoro, G. Catania, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano, R Varaldo
Journal: Blood
Blood (2008) 112 (11): 3294.
https://doi.org/10.1182/blood.V112.11.3294.3294
Published: 2008
Journal Articles

Late Platelets Recovery after Autografting (ASCT) in Patients with Acute Myeloid Leukemia (AML) Is A Prognostically Favourable Factor for Long-Term Remission

A. M. Carella, G Catania, R Varaldo, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano
Journal: Blood
Blood (2008) 112 (11): 4433.
https://doi.org/10.1182/blood.V112.11.4433.4433
Published: 2008
Journal Articles

Reduced-Intensity Conditioning for Allografting Following Autografting for Myeloma: Lower Relapse Rates Compared with Single or Double Autografting but Similar Overall Survival. The Genoa Experience in 74 Patients.

A.M. Carella, MD, G. Catania, MD, S. Biasco, MD, M. Congiu, MD, S. Nati, MD, E. Rossi, MD, R. Vimercati, MD, D. Ciapanna, MD, M. Spriano, MD
Journal: Blood
Blood (2007) 110 (11): 5095.
https://doi.org/10.1182/blood.V110.11.5095.5095
Published: 2007